In group B Cystatin C was, too but not closely than in group A (r=0, 407; p< 0, 05; r = 0, 374; p <0, 05) respectively This showed serum Cystatin C was better than serum creatinine in detecting the early decreasing of GFR in type 2 diabetes patients with MA.